ClinicalTrials.gg

Sanofi clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 2,424 studies whose lead sponsor is Sanofi or one of 19 companies grouped under it. 104 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 20 registry names, not the registry’s. See them and correct one ↓

Compare Sanofi with AbbVie and Innovent Biologics →

Pipeline: 79 programs

Each counted once: 72 with a study Sanofi leads registered in the last two years, 7 more from Sanofi's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by Sanofi only (no registered study yet; not in the 79)

The 5 of 21 with the most live studies.

Program
rilzabrutinibSAR444671Phase 3 · 11 live · Purpura, Thrombocytopenic, Idiopathic · primary completion Nov 2026☆ Track
frexalimabPhase 3 · Sanofi: Phase 3 · 9 live · Multiple Sclerosis · primary completion Dec 2026☆ Track
Pneumococcal 21-Valent Conjugate VaccinePhase 3 · 7 live · Pneumococcal Infections · primary completion Dec 2026☆ Track
lunsekimigPhase 3 · Sanofi: Phase 3 · 6 live · Asthma · primary completion Jun 2027☆ Track
duvakitugPhase 3 · Sanofi: Phase 3 · 6 live · Crohn Disease · primary completion May 2028☆ Track

16 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sanofi’s own registered studies; “Sanofi says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Sanofi’s programs has a dated deal behind it: 1 developed with a partner. Each from the companies’ own releases and filings, linked; the registry does not record them.

Developed with a partner 1

  • duvakitug — developed with Teva, Teva leads sales in Europe and Israel, Sanofi in North America, Japan and elsewhere.Announced Oct 4, 2023 · Source: Sanofi, Oct 4, 2023

What it is testing

The drugs Sanofi’s studies test, most open studies first — 319 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 319; every drug is on its own page, and each page lists its sponsors.

Coming up

65 of Sanofi’s studies under way reach primary completion within a year, 21 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 5N’26
  2. 7D
  3. 6J’27
  4. 4F
  5. 3M
  6. 8A
  7. 8M
  8. 8J
  9. 3J
  10. 2A
  11. 4S
  12. 4O
  13. 3N

The 12 nearest

Show 7 more

Add all 65 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered13

Show 8 more

All 2,424 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1044%Recruiting 87 · Not yet recruiting 12 · Enrolling by invitation 5
  • Under way, not recruiting874%
  • Completed1,92779%
  • Stopped early29112%Terminated 267 · Withdrawn 23 · Suspended 1
  • Status unknown or other151%Approved for marketing 6 · Status unknown 5 · No longer available 3 · Available 1

Phase

Where

Over the years

  1. 07
  2. 15308
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 5526

By the year each study started; 712 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sanofi.

  • Sanofi
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1,559 studies
  • Sanofi Pasteur, a Sanofi Company
    Acquired — became part of Sanofi, Aug 20, 2004 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    374 studies →
  • Genzyme, a Sanofi Company
    Acquired — became part of Sanofi, Apr 4, 2011 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    308 studies →
  • Blueprint Medicines Corporation
    Acquired — became part of Sanofi, Jul 18, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    32 studies →
  • Ablynx, a Sanofi company
    Acquired — became part of Sanofi, May 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies →
  • Dynavax Technologies Corporation
    Acquired — became part of Sanofi, Feb 10, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies →
  • Kadmon Corporation, LLC
    Acquired — became part of Sanofi, Nov 9, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    20 studies →
  • Bioverativ, a Sanofi company
    Acquired — became part of Sanofi, Mar 8, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Kadmon, a Sanofi Company
    Acquired — became part of Sanofi, Nov 9, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • Bioverativ Therapeutics Inc.
    Acquired — became part of Sanofi, Mar 8, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • Principia Biopharma, a Sanofi Company
    Acquired — became part of Sanofi, Sep 28, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Kymab Limited
    Acquired — became part of Sanofi, Apr 9, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Chattem, Inc.
    Acquired — became part of Sanofi, Feb 9, 2010 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Provention Bio, Inc.
    Acquired — became part of Sanofi, Apr 27, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Provention Bio, a Sanofi Company
    Acquired — became part of Sanofi, Apr 27, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Vigil Neuroscience, Inc.
    Acquired — became part of Sanofi, Aug 6, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Opella Healthcare Group SAS, a Sanofi Company
    Divested — left Sanofi, Apr 30, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Aventis Pharmaceuticals
    Acquired — became part of Sanofi, Aug 20, 2004 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Translate Bio, Inc.
    Acquired — became part of Sanofi, Sep 14, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Synthorx, Inc, a Sanofi company
    Acquired — became part of Sanofi, Jan 23, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Sanofi leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 72 areas

Studies

Recruiting first, then most recently updated. Showing 50 of 2,424. Browse all 2,424 →